The anti-Covid vaccine from Novavax is placed, that of Janssen is replaced. The High Authority for Health (HAS) recommended, on January 14, to grant the first a place in the vaccine campaign as a primary vaccination, and to allow the second to now be used as a second heterologous dose (after a first dose with another vaccine) and as a booster. These two recommendations are intended to beef up the vaccine campaign, in the midst of the epidemic resumption, and to provide solutions for people who do not wish to use mRNA and latest generation vaccines, knowing that just under 5 million people in France do not have not yet received a single dose. This also offers an alternative to people who cannot use mRNA vaccines due to medical contraindications in particular.
Source: UsineNouvelle – Actualités A la une by www.usinenouvelle.com.
*The article has been translated based on the content of UsineNouvelle – Actualités A la une by www.usinenouvelle.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!